Stocks
Evolent Health (EVH) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 43.0 | 6.58 | -18.2 | 21.7 | -3.58 | 12.9 | ||
| Changes by years, y/y, % | -847% | -85% | -377% | -219% | -117% | -9.1% | |||
Evolent Health. EV/EBITDA
Evolent Health. EV/EBITDA, changes, %
Evolent Health (EVH) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | 169.5 | 83.2 | -3.63 | -3.42 | -4.62 | 12.9 | |
| Changes by years, y/y, % | +2 036% | +34% | -115% | -107% | -103% | |||
| Changes by quarters, q/q, % | +225% | -51% | -104% | -6% | +35% | |||
